The company aims to further enhance confidence in a patient’s diagnosis, especially in cases of discriminating lung SqCC versus ADC, where a correct diagnosis is critical for therapeutic direction.
Read More
Researchers raise alarm about loss of individual genomic liberty due to gene patents that may impact the era of personalized medicine.
Read More
Discover new products on the market.
Read More
Including p63 in Biocare’s lung, prostate, and breast panels empowers its Multiplex IHC platform to aid pathologists in making critical decisions.
Read More
Data published in Journal of Thoracic Oncology.
Read More